凯沃尔基安刮匙。对其在子宫内膜评估中有效性的评价。

The Kevorkian curette. An appraisal of its effectiveness in endometrial evaluation.

作者信息

Ferenczy A, Shore M, Guralnick M, Gelfand M M

出版信息

Obstet Gynecol. 1979 Aug;54(2):262-7.

Abstract

Office endometrial biopsy with the Kevorkian curette was performed in 400 patients presenting with abnormal uterine bleeding or other endometrial cancer-risk indicators. The use of this instrument has proved to be a safe, simple, inexpensive, and highly reliable outpatient procedure with excellent patient acceptance. It has provided tissue for adequate diagnosis in 91.8% of the cases, and the diagnostic accuracy when controlled by D&C and/or total abdominal hysterectomy (TAH) was 96.2%. As a result, 73.5% of the women required no further surgical procedures for either diagnostic or therapeutic purposes. In the postmenopausal age group, adenocarcinoma was diagnosed in 7 of 177 (3.9%) women. This procedure is highly recommended for early office diagnosis of uterine pathology and, in particular, endometrial adenocarcinoma and its presumed precursor lesion, adenomatous hyperplasia.

摘要

对400例有异常子宫出血或其他子宫内膜癌风险指标的患者进行了使用凯沃尔基安刮匙的门诊子宫内膜活检。事实证明，使用这种器械是一种安全、简单、廉价且高度可靠的门诊手术，患者接受度很高。它在91.8%的病例中提供了足够用于诊断的组织，经刮宫术和/或全腹子宫切除术（TAH）对照后的诊断准确率为96.2%。因此，73.5%的女性无需进一步进行诊断或治疗性手术。在绝经后年龄组中，177名女性中有7名（3.9%）被诊断为腺癌。强烈推荐该手术用于子宫病变尤其是子宫内膜腺癌及其假定的前驱病变腺瘤样增生的早期门诊诊断。